EsophyX is a novel endolumenal therapeutic option for the treatment of gastroesophageal reflux disease (GERD). The device is passed into the stomach, where it deploys a series of full-thickness fasteners to create a neogastroesophageal valve. The objective of this study was to demonstrate the safety and characterize the effectiveness of this approach in the initial North American experience. This is a retrospective study of consecutive patients with GERD who had undergone endolumenal fundoplication with the EsophyX device. At follow-up, proton pump inhibitor usage was elicited and 2 validated questionnaires were administered measuring GERD health-related quality of life (range 0-50) and symptom severity (range 0-72). In limited preliminary evaluation, the initial North American experience with endolumenal fundoplication using the EsophyX device is that it appears to be safe and provides moderate effectiveness in treating the symptoms of GERD. Further studies comparing this technique with conventional medical and surgical therapies are necessary.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1553350608321588 | DOI Listing |
Am Surg
May 2022
Department of Surgery, 24729Chesapeake Regional Medical Center, Chesapeake, VA, USA.
Background: The surgical management of gastroesophageal reflux disease (GERD) involves extensive diagnostic studies and sophisticated surgical techniques. The workup should be comprehensive and purposeful. High resolution impedance manometry (HRIM) provides valuable information regarding peristalsis and lower esophageal sphincter relaxation.
View Article and Find Full Text PDFAm Surg
November 2020
Surgical Services, Aspirus Iron River Hospital & Clinics, Iron River, MI, USA.
Non-ablative radiofrequency treatment to the lower esophageal sphincter (Stretta) has been shown to be beneficial after failed Nissen fundoplication. To our knowledge, this is the first report of Stretta after transoral incisionless fundoplication (TIF). This patient is a 17-year-old female who had gastroesophageal reflux disease (GERD) symptoms for 9 years.
View Article and Find Full Text PDFGastrointest Endosc Clin N Am
January 2013
Esophageal and Foregut Surgery, Division of Gastrointestinal and Minimally Invasive Surgery, The Oregon Clinic, Portland, OR 97213, USA.
TIF Stretta and Endocinch all seem technically safe in well-selected patients including those with prior esophageal and gastric surgeries. Long-term effectiveness is being evaluated. Given the current enthusiasm for increasingly less invasive surgical techniques, the inertia for endolumenal therapies continues to grow.
View Article and Find Full Text PDFJ Gastrointest Surg
July 2011
Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Shadyside Medical Center, Suite 715, 5200 Centre Avenue, Pittsburgh, PA 15232, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!